Position in JNJ
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$53,266,397
+$1,759,957 QoQ
Shares Held
209,735
-0.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
2.82%
of 13F equity value
Holder Rank
#429
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesley Taft & Associates LLC holds $123,067,788 across 10 Drug Manufacturers - General names. JNJ ranks #1 (43.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
209,735 | $53,266,397 | |
| 2 | LLY |
ELI LILLY & Co
|
20,347 | $24,404,803 | |
| 3 | AZN |
Astrazeneca PLC
|
81,276 | $15,411,554 | |
| 4 | MRK |
Merck & Co., Inc.
|
55,810 | $7,171,585 | |
| 5 | AMGN |
Amgen Inc
|
18,897 | $6,842,981 | |
| 6 | NVS |
Novartis AG
|
32,410 | $5,079,295 | |
| 7 | ABBV |
AbbVie Inc.
|
19,924 | $5,013,674 | |
| 8 | PFE |
Pfizer Inc
|
194,317 | $4,679,152 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,266,397 | 209,735 | Shares | Other | 2026-07-08 | |
| 2026-03-31 | $51,506,440 | 210,712 | Shares | Other | 2026-04-13 | |
| 2025-12-31 | $44,060,274 | 212,903 | Shares | Other | 2026-01-14 | |
| 2025-09-30 | $36,736,708 | 198,127 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $31,064,920 | 203,371 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $33,941,809 | 204,666 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $29,984,787 | 207,335 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $33,844,610 | 208,840 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $30,829,236 | 210,928 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $32,991,315 | 208,555 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $32,609,443 | 208,048 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $32,854,060 | 210,941 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $35,243,180 | 212,924 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $34,962,420 | 225,564 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $40,044,081 | 226,686 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $36,948,601 | 226,179 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $40,328,141 | 227,188 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $40,358,461 | 227,718 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $40,068,186 | 234,221 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $37,434,408 | 231,792 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $38,223,633 | 232,024 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $38,404,157 | 233,673 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $36,386,885 | 231,204 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $34,440,112 | 231,328 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $31,751,582 | 225,781 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $27,971,733 | 213,313 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||